MarkNtel Advisors recently published a detailed industry analysis of the Global Cardiac AI Monitoring and Diagnostics Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Cardiac AI Monitoring and Diagnostics Market, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030

The Cardiac AI Monitoring and Diagnostics Market size is estimated to grow at a CAGR of around 25.6% during the forecast period, i.e., 2024–30.

Key Findings in Global Cardiac AI Monitoring and Diagnostics Market:

• Historical Analysis: 2019–2022
• Base Year: 2023
• Forecast Period: 2024–2030

Leading Market Players- HeartVista, Inc., Siemens Healthineers AG, RSIP Vision, Ultromics Limited., Tempus Labs, Inc., Cardiologs Technologies, Cleerly, Inc., AliveCor, Inc., Aidoc Medical Ltd., Boston Scientific Corporation, CathWork Inc., HeartFlow, Inc., iRhythm Technologies, Inc., Nano-x Imaging Ltd., etc.

Key Highlights of the Report

• Market Dimensions & Projections
• Pricing Evaluation,
• Recent Strategic Moves by Companies,
• Primary Stakeholders,
• Analysis of Import and Export Trends,
• Competitive Landscape Assessment,
• Emerging Opportunities,
• Market Trends and Indicators

What are the major Driver the Global Cardiac AI Monitoring and Diagnostics Market?

Rising Incidence of Coronary Artery Diseases – With the rising incidence of coronary artery diseases worldwide, especially across Asia-Pacific, and Europe, owing to the rising adoption of unhealthy and sedentary lifestyles among consumers, demand for monitoring and diagnosis services has been increasing significantly across the globe. Additionally, other health factors, including physical inactivity, being overweight, unhealthy eating, and smoking tobacco, have been causing the deposition of plaque and cholesterol in blood vessels, causing cardiovascular diseases (CVD). For instance,

• According to the British Heart Foundation, in 2022, globally, 1 in every 14 people was living with coronary heart disease, either linked to the heart or circulatory vessels.

Consequently, as the number of patients suffering from CVD has been increasing, healthcare professionals have started inclining toward AI software and services over the years. The inclination toward AI software in cardiovascular diagnosis and monitoring has been attributed to the ease of processing large amounts of data generated from these diagnostic devices within a minimum amount of time. Henceforth, with the rising number of heart diseases, coupled with growing health facilities adopting AI software in the cardiology segment across regions like North America, Asia Pacific, etc., the market would witness considerable growth & expansion during the forecast period.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

https://www.marknteladvisors.com/query/request-sample/cardiac-ai-monitoring-diagnostics-market.html

What segments define the Global Cardiac AI Monitoring and Diagnostics Market from 2024 to 2030? How do these segments contribute to market dynamics and growth?

By Product

• • Software- Market Size & Forecast 2019-2030, USD Million
  • Hardware- Market Size & Forecast 2019-2030, USD Million

By Type

• • Cardiac Diagnostics- Market Size & Forecast 2019-2030, USD Million
    • Cardiac Imaging- Market Size & Forecast 2019-2030, USD Million
    • Electrocardiography-Based (ECG-Based) Diagnostics- Market Size & Forecast 2019-2030, USD Million
    • Others (Blood Biomarker Analysis, Cardiac Stress Testing, etc.) - Market Size & Forecast 2019-2030, USD Million
  • Cardiac Monitoring- Market Size & Forecast 2019-2030, USD Million

According to report, Cardiac diagnostics has been dominating the Global Cardiac AI Monitoring and Diagnostics Market over the past few years.

By Indication

• • Hypertension (High Blood Pressure)- Market Size & Forecast 2019-2030, USD Million
  • Coronary Artery Disease (CAD)- Market Size & Forecast 2019-2030, USD Million
  • Arrhythmias- Market Size & Forecast 2019-2030, USD Million
  • Cardiomyopathies- Market Size & Forecast 2019-2030, USD Million
  • Others (Valvular Heart Disease, Peripheral Artery Disease (PAD), etc.) - Market Size & Forecast 2019-2030, USD Million

By End-User

• • Hospitals - Market Size & Forecast 2019-2030, USD Million
  • Diagnostic Centers- Market Size & Forecast 2019-2030, USD Million
  • Specialty Cardiology Clinics- Market Size & Forecast 2019-2030, USD Million
  • Ambulatory Surgical Centers- Market Size & Forecast 2019-2030, USD Million

According to report, Among them, the hospital segment dominated the Global Cardiac AI Monitoring and Diagnostics Market, claiming the majority of the market share.

Explore the Complete Global Cardiac AI Monitoring and Diagnostics Market Analysis Report – https://www.marknteladvisors.com/research-library/cardiac-ai-monitoring-diagnostics-market.html

Geographical Analysis: Global Cardiac AI Monitoring and Diagnostics Market

 By Region

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

  Global Cardiac AI Monitoring and Diagnostics Market Recent Development:

• 2023: Ultromics Limited, introduced EchoGo® Heart Failure, an AI solution for echocardiography, which has achieved clearance from the US Food and Drug Administration (FDA). EchoGo® Heart Failure is an AI-powered platform designed for precise identification of heart failure with preserved ejection fraction (HFpEF).

• 2022: iRhythm Technologies, Inc., received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System designed for the Zio Watch. Developed in partnership with Verily, an Alphabet precision health company, the ZEUS System combines advanced deep learning algorithms with a trusted cardiac arrhythmia service.

Key Questions Addressed in This Study

• What are the primary factors driving the growth of the Global Cardiac AI Monitoring and Diagnostics Market?
• How is the Global Cardiac AI Monitoring and Diagnostics Market expected to evolve over the next five years?
• What key insights can be drawn from current trends shaping the market?
• What is the current market size, and how is it forecasted to change in the coming years?
• What is the future outlook for the market in terms of technological innovation and geographic expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/cardiac-ai-monitoring-diagnostics-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2025 and is projected to reach USD 89 billion by 2030 with a CAGR of around 125.6%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2025 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Email: sales@marknteladvisors.com

Trending Blogs : www.marknteladvisors.com/blogs

Export-import Data : https://www.marknteladvisors.com/export-import-data